See more : Goodbaby International Holdings Limited (GBBYF) Income Statement Analysis – Financial Results
Complete financial analysis of Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhong Yuan Bio-Technology Holdings Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Afry AB (AFRY.ST) Income Statement Analysis – Financial Results
- Himalaya Shipping Ltd. (HSPPF) Income Statement Analysis – Financial Results
- LOCONDO, Inc. (3558.T) Income Statement Analysis – Financial Results
- Ventoux CCM Acquisition Corp. (VTAQU) Income Statement Analysis – Financial Results
- Weigang Environmental Technology Holding Group Limited (1845.HK) Income Statement Analysis – Financial Results
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
About Zhong Yuan Bio-Technology Holdings Limited
Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Wanchai, Hong Kong.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.28M | 1.66M | 2.33M | 1.64M | 1.22M | 1.22M | 0.00 | 0.00 |
| Cost of Revenue | 206.37K | 144.68K | 420.27K | 281.96K | 257.03K | 320.84K | 0.00 | 0.00 |
| Gross Profit | 2.07M | 1.52M | 1.91M | 1.35M | 962.62K | 896.75K | 0.00 | 0.00 |
| Gross Profit Ratio | 90.94% | 91.30% | 81.95% | 82.76% | 78.93% | 73.65% | 0.00% | 0.00% |
| Research & Development | 493.84K | 357.82K | 680.31K | 211.04K | 182.31K | 42.70K | 0.00 | 0.00 |
| General & Administrative | 897.52K | 753.69K | 1.03M | 574.63K | 598.61K | 373.90K | 0.00 | 0.00 |
| Selling & Marketing | 413.96K | 1.66M | 887.97K | 582.38K | 267.21K | 168.01K | 0.00 | 0.00 |
| SG&A | 1.31M | 2.41M | 1.91M | 1.16M | 865.82K | 541.91K | 27.19K | 2.75K |
| Other Expenses | 0.00 | 0.00 | 2.55K | 11.13K | 1.87K | 303.00 | 0.00 | 0.00 |
| Operating Expenses | 1.81M | 2.77M | 2.55M | 1.37M | 1.05M | 584.62K | 27.19K | 2.75K |
| Cost & Expenses | 2.01M | 2.92M | 2.97M | 1.65M | 1.31M | 905.45K | 27.19K | 2.75K |
| Interest Income | 24.47K | 605.00 | 163.00 | 90.00 | 2.45K | 605.00 | 0.00 | 0.00 |
| Interest Expense | 81.32K | 46.72K | 35.24K | 24.65K | 6.12K | 20.08K | 0.00 | 0.00 |
| Depreciation & Amortization | 122.53K | 170.33K | 183.38K | 182.37K | 19.58K | 5.92K | 27.19K | 2.75K |
| EBITDA | 475.12K | -1.54M | -452.93K | 179.00K | -61.61K | 318.06K | 0.00 | 0.00 |
| EBITDA Ratio | 20.85% | -92.76% | -19.45% | 10.95% | -5.05% | 26.20% | 0.00% | 0.00% |
| Operating Income | 266.56K | -1.25M | -685.76K | -14.60K | -85.51K | 312.14K | -27.19K | -2.75K |
| Operating Income Ratio | 11.70% | -75.39% | -29.45% | -0.89% | -7.01% | 25.64% | 0.00% | 0.00% |
| Total Other Income/Expenses | 4.72K | -505.72K | 14.22K | -13.43K | -1.79K | -16.04K | 0.00 | 0.00 |
| Income Before Tax | 271.28K | -1.76M | -671.54K | -28.02K | -87.30K | 296.10K | -27.19K | -2.75K |
| Income Before Tax Ratio | 11.91% | -105.81% | -28.84% | -1.71% | -7.16% | 24.32% | 0.00% | 0.00% |
| Income Tax Expense | -594.00 | -8.84K | 11.12K | 660.00 | 7.99K | 15.91K | -27.19K | 0.00 |
| Net Income | 302.21K | -2.23M | -1.13M | -28.02K | -87.30K | 280.18K | -27.19K | -2.75K |
| Net Income Ratio | 13.27% | -134.19% | -48.34% | -1.71% | -7.16% | 23.01% | 0.00% | 0.00% |
| EPS | 0.00 | -0.12 | -0.07 | 0.00 | -0.01 | 0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.12 | -0.07 | 0.00 | -0.01 | 0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 17.67M | 17.28M | 17.15M | 17.15M | 17.15M | 17.15M | 2.00M |
| Weighted Avg Shares Out (Dil) | 0.00 | 17.67M | 17.28M | 17.15M | 17.15M | 17.15M | 17.15M | 2.00M |
Source: https://incomestatements.info
Category: Stock Reports